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The seroprevalence of Rickettsia conorii in humans living in
villages of Tokat Province in Turkey, where Crimean-Congo
hemorrhagic fever virus is endemic, and epidemiological
similarities of both infectious agents
Turabi GÜNEŞ1, Ömer POYRAZ2, Mehmet ATAŞ 3, Nergiz Hacer TURGUT1

Aim: Tokat Province is an epicenter for Crimean-Congo hemorrhagic fever virus (CCHFV) in Turkey. The aim of this
study was to investigate the seroprevalence of Rickettsia conorii and to clarify the epidemiological similarities between
CCHFV and R. conorii in Tokat Province.
Materials and methods: The prevalence of antibodies reactive with R. conorii was examined by ELISA in 364 sera, 151
of which were seropositive for CCHFV.
Results: The overall prevalence of antibodies reactive with R. conorii was 36.81%. The prevalence of antibodies to R.
conorii infection was higher in humans who showed CCHFV seropositivity than seronegativity, 52.32% and 25.82%,
respectively (P = 0.001). A significant difference in seroprevalence was found between groups who had a history of tick
bite and who did not, 41.52% and 29.29%, respectively (P = 0.019).
Conclusion: Our data show that people who are a risk group for CCHFV are likely to be a risk group for R. conorii.
Key words: Rickettsia conorii, Mediterranean spotted fever, seroprevalence, Crimean-Congo hemorrhagic fever, tickborne infections, Turkey

Kırım Kongo hemorajik ateş virüsünün endemik olduğu Tokat’ın
köylerinde yaşayan insanlarda Rickettsia conorii seroprevalansı ve
her iki enfeksiyon etkeninin epidemiyolojik benzerlikleri
Amaç: Tokat, Kırım-Kongo Hemorajik Ateş Virüsü (CCHFV) yönünden yüksek derece endemik bir yöredir. Bu
çalışmanın amacı, Tokat yöresinde Rickettsia conorii’nin seroprevalansını araştırmak ve CCHFV’ü ve Rickettsia conorii
arasındaki epidemiyolojik benzerlikleri ortaya koymaktır.
Yöntem ve gereç: 151’i CCHFV’ü yönünden seropozitif olmak üzere, toplam 364 serum örneğinde ELISA yöntemi ile
R. conorii ile reaktif antikorların prevalansı araştırılmıştır.
Bulgular: R. conorii ile reaktif antikorların genel prevalansı % 36,81 olarak saptanmıştır. R. conorii enfeksiyonuna karşı
oluşmuş antikor prevalansı, CCHFV seropozitifliği olanlarda, seronegatiflere göre daha yüksek tespit edilmiş olup
sırasıyla % 52,32 ve % 25,82 oranlarında saptanmıştır (P = 0,001). Kene ısırığı öyküsü olanlarda % 41,52 ve olmayanlarda
% 29,29 oranında görülmesiyle, gruplar arasında seroprevalans bakımından anlamlı bir farklılık bulunmuştur (P =
0,019).
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Sonuç: Bulgularımız CCHFV yönünden risk grubundan olan insanların R. conorii yönünden de risk grubundan
olmasının muhtemel olduğunu göstermiştir.
Anahtar sözcükler: Rickettsia conorii, Akdeniz benekli ateşi, seroprevalans, Kırım kongo hemorajik ateşi, kene-kaynaklı
enfeksiyonlar, Türkiye

Introduction
Tick-borne rickettsioses are caused by obligate
intracellular bacteria belonging to the spotted fever
group (SFG) of the genus Rickettsia within the family
Rickettsiaceae in the order Rickettsiales. Spotted fever
rickettsia (SFR) is among the oldest known vectorborne diseases. In 1906, it was stated that the Rocky
Mountain spotted fever (RMSF) caused by Rickettsia
rickettsii and also in 1925 the Mediterranean spotted
fever (MSF) caused by Rickettsia conorii are related
with tick bite (1,2).
MSF, also known as Boutonneuse fever, is a
zoonosis caused by R. conorii and transmitted by
the brown dog tick, Rhipicephalus sanguineus. MSF
occurs throughout southern Europe, Africa, and in
Western to Central Asia (3). R. conorii infects and
multiplies in almost all organs of ticks, in particular
the salivary glands, which enables the rickettsiae to be
transmitted to vertebrate hosts during feeding (1,2).
In 80% of patients there was a previous dog contact
history. Subsequent to tick bite, after 6-10 days,
symptoms such as high fever, headache and myalgia
appear. Approximately 3 days after the occurrence
of high fever, maculopapular rash appears in 95% of
patients (3).
The diagnosis of infections is made through
serological tests, immunodetection of organisms in
blood samples and tissues, isolation of organisms
in cell culture, and identification of organisms by
molecular-based methods (1,2). In serology and
epidemiologic research, indirect immunofluorescence
(IFA) is the most commonly used technique, but it
can be replaced by enzyme-linked immunosorbent
assay (ELISA) with similar sensitivity and specificity
results (4,5).
R. sanguineus ticks are found in all regions of
Turkey (6). The presence of MSF cases has been
shown on a molecular basis in Turkey (7), and with
seroepidemiological studies it has been shown that
this agent can lead to an important health problem (8).
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In recent years, in Tokat Province, Turkey, especially
people living in villages are exposed to tick bites and
CCHF cases are frequently seen in this region (9-11).
The aim of this study was to examine the prevalence
of antibodies reactive with R. conorii in humans from
rural villages, which is endemic for CCHFV, in Tokat
Province and to clarify epidemiological similarities
between CCHFV and R. conorii.
Materials and methods
Study area
Tokat is located in the inner part of the Middle Black
Sea region of Turkey (Figure 1). The climate of Tokat
features a transition between the climate of the Black
Sea region and the climate of the Central Anatolia.
Tokat Province has lands within the Kelkit valley
and has appropriate vegetation cover for wild and
domestic animals, which can be hosts for ticks (12).
This region has also been considered an epicenter for
CCHFV epidemics (9,10).
Collecting blood samples
The statistical parameters used to calculate the
sample size were at a 95% confidence level, and
error limits were of ±5% for the total population of
500,000. The prior estimated rate of seroprevalence
for R. conorii was 20%, based on seroprevalence
data from previous studies (8), and the estimated
sample size required was 246. In the current study,
364 serum samples, of which 151 were seropositive
and 213 seronegative for CCHFV, were used. The
294 of the 364 serum samples were provided from
our previous study in which we had investigated the
seroprevalence of CCHFV in 644 serum samples
(10), from 43 villages (throughout 9 districts of Tokat
Province), which were endemic for CCHFV (Figure
1). The remaining 70 of the 364 serum samples were
provided from 70 patients (from the same villages)
who were treated for CCHFV at the Medical School
Hospital of Cumhuriyet University.
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Figure 1. Geographic location of Tokat and the areas where blood samples were
collected from humans.

Eighty-one of the 644 stock serum samples
were seropositive for CCHFV, and 563 of them
were seronegative. To be used in this study, 213
seronegative sera in terms of CCHFV were randomly
selected from 563 seronegative stock serum samples.
Because the size of the sample is limited, random
selection was not used in the selection of the 81
seropositive samples to CCHFV or in the selection
of the 70 samples from patients who were treated for
CCHFV.
Serologic tests
Three hundred and sixty-four serum samples, of
which 151 were positive (Group 1) and 213 negative
(Group 2) for CCHFV, were included in the study to
investigate R. conorii. Because 294 serum samples
were known in terms of CCHFV serology (10), there
was no need for investigation of antibodies against
CCHFV in these sera. To justify the presence of
CCHFV antibodies, the remaining 70 serum samples
collected from patients who were treated for CCHF
at the Medical School Hospital of Cumhuriyet
University were tested for antibodies of CCHFV
using immunoglobulin G (IgG) ELISA kits (VectorBest; Kolsovo Novosibirsk, Russia). The presence of
antibodies against R. conorii (Strain: Moroccan) was

determined using ELISA (Vircell Microbiologists,
Granada, Spain). Both tests were performed
according to the manufacturers’ instructions and
optical densities (OD) of samples were measured
at 450 nm using an EL 312 Microplate Bio-kinetics
Reader (Bio-Tek Instruments, Inc., Winooski,
Vermont, USA).
Statistical analysis
A chi-squared test and a binary logistic regression
analysis were used to evaluate risk factors associated
with seroprevalence of R. conorii, including age,
sex, tick bite, and tick contacts. Phi correlation and
Spearman’s rank correlation tests (Spearman’s rho)
were used to examine the relationship between
parameters. Statistical analyses were performed with
SPSS, Ver. 17 (SPSS, Inc., Chicago, IL, USA) and
statistical significance was defined as a 2-tailed P
value ≤0.05.
Results
All of the serologic findings of the current study are
presented in Tables 1 and 2. Of the 364 high-risk
individuals, whose mean age was 44.93 years (SD ±
17.48), 134 (36.81%) were positive for IgG against
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Table 1. Demographics and seroprevalence of R. conorii.
X2 (P)

Odds ratio (95% CI)

55 (31.07)
79 (42.25)

4.80 (0.027)

1.62 (1.05-2.50)

140
224

41 (29.29)
93 (41.52)

5.54 (0.019)

1.71 (1.09-2.69)

Tick removal from the animals
No
Yes

117
247

45 (38.46)
89 (36.03)

0.20 (0.654)

0.90 (0.57-1.42)

Occupational groups
Farming and animal husbandry
Only farmer
Retired, students, etc.

318
22
24

120 (37.74)
8 (36.36)
6 (25.00)

1.56 (0.459)

0.78 (0.51-1.19)

Age, 45
Age ≤ 45 years
Age > 45 years

177
187

36 (20.34)
98 (52.41)

40.20 (0.001)

4.31 (2.71-6.87)

Age groups (means)
9-20 (15.26)
21-30 (25.59)
31-40 (35.68)
41-50 (45.62)
51-60 (55.61)
61-70 (64.35)
71-80 (74.79)

42
41
62
66
75
54
24

4 (9.52)
7 (17.07)
13 (20.97)
25 (37.88)
38 (50.66)
32 (59.26)
15 (62.50))

51.73 (0.001)

1.65 (1.42-1.91)

Co-seroprevalence
R. conorii and CCHFV

644

49 (7.61)

Risk factor category

n

Positive (%)

Total

364

134 (36.81)

Gender
Female
Male

177
187

History of tick bite
No
Yes

CI = Confidence interval

R. conorii. Fifty-five (31.07%) of the 177 female
participants and 79 (42.25%) of 187 male participants
were seropositive for R. conorii (X2 = 4.80, P = 0.027,
Odds ratio [OR] = 1.62). Co-seroprevalence with
CCHFV and R. conorii was detected in 49 (7.61%)
of the 644 participants who had been previously
investigated for CCHFV serology.
The seroprevalence of the antibodies reactive with
R. conorii was higher in the older age groups than in
the younger age groups (X2 = 51.73, P = 0.001, OR
= 1.65) (Table 1, Figure 2). A statistically significant
correlation was observed between the means of age
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groups and the prevalence of antibodies to R. conorii
in age groups (Spearman’s rho = 0.98, P = 0.001), and
also the scatter plot curve between them shows the
direction of correlation (Figure 3).
Although a significant difference in the prevalence
of antibody to R. conorii was found between groups
in terms of history of tick bite (41.52% and 29.29%,
respectively) (X2 = 5.54, P = 0.019, OR = 1.71), a
statistical difference was not seen between people
who removed the ticks by hand and with people
who had no contact with ticks (36.03% and 38.46%,
respectively) (X2 = 0.20, P = 0.654, OR= 0.90).
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Table 2. Demographics and seroprevalence of R. conorii in people who had CCHFV antibody and those who did not.
Group 1*

Group 2†

Risk factor category
n

Positive (%)

n

X2 (P)‡

Odds (95% CI)#

Positive (%)

Total

151

79 (52.32)

213

55 (25.82)

25.54 (0.001)

3.15 (2.02-4.91)

Gender
Female
Male

73
78

33 (45.21)
46 (58.97)

104
109

22 (21.15)
33 (30.28)

10.49 (0.001
14.19 (0.001)

3.08 (1.60-5.94)
3.31 (1.80-6.09)

History of tick bite
No
Yes

34
117

16 (47.06)
63 (53.85)

106
107

25 (23.59)
30 (28.04)

5.76 (0.016)
14.28 (0.001)

2.88 (1.28-6.47)
2..99 (1.72-5.23)

Tick removal from the animals
No
Yes

48
103

23 (47.92)
56 (54.37)

69
144

22 (31.88)
33 (22.92)

2.43 (0.118)
24.43 (0.001)

1.97 (0.92-4.20)
4.00 (2.32-6.94)

Occupational groups
Farming and animal husbandry
Only farmer
Retired, students, etc.

141
6
4

73 (51.77)
4 (66.67)
2 (50.00)

177
16
20

47 (26.55)
4 (25.00)
4 (20.00)

20.18 (0.001)
(0.137)
(0.251)

2.97 (1.86-4.75)
6.00 (0.78-46.14)
4.00 (0.42-37.78)

Age, 45
Age ≤ 45 y
Age > 45 y

54
97

19 (35.19)
60 (61.86)

123
90

17 (13.82)
38 (42.22)

10.57 (0.001)
7.21 (0.007)

3.39 (1.59-7.22)
2.22 (1.24-3.99)

* = Seropositive people for CCHFV, † = Seronegative people for CCHFV, ‡, #. = Groups 1 and 2 were compared with each other,
CI = Confidence interval.
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Figure 2. Distribution of prevalence of antibodies against R.
conorii by age groups.

Figure 3. Scatterplot curve between mean of age groups and
seroprevalence of age groups for R. conorii.

Furthermore, a statistical difference was not observed
among professional groups for the distribution of
positive antibody against R. conorii (X2 = 1.56, P =
0.459).

In 79 of 151 (52.32%) people with positive
antibody against CCHFV (Group 1) and in 55 of 213
(25.82%) people with no CCHFV antibody (Group
2), antibodies against R. conorii were detected (X2
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= 25.54; P = 0.001, OR = 3.15). The mean ages of
Groups 1 and 2 were 49.97 (SD ± 16.54) and 41.35
(SD ± 17.28), respectively. History of tick bite was
recorded for 117 of 151 people (77.48%) in Group 1
and for 107 of 213 people (50.23%) in Group 2 (X2
= 27.72, P = 0.001). In people with history of tick
bite, a higher seroprevalence of antibodies reactive
with R. conorii was detected in Group 1 compared
to Group 2 (53.85% and 28.04%, respectively) (X2 =
14.28, P = 0.001, OR = 2.99). In addition, in people
with no previous tick bite, a higher seroprevalence
of antibodies reactive with R. conorii was detected in
Group 1 compared to Group 2 (47.06% and 23.59%,
respectively) (X2 = 5.76, P = 0.016, OR = 2.88).
Additionally, for other parameters (such as gender,
occupational groups, being over or under 45 years of
age) a higher seroprevalence of antibodies reactive
with R. conorii was detected in Group 1 compared to
Group 2 (Table 2).
Discussion
In the Mediterranean region, the incidence of MSF
is generally estimated from 1 to 50 cases per 100,000
(annually), depending on the geographical area (1317). In Turkey, MSF case reports are extremely limited
and most of them are in the Marmara region (7). Some
authors suggest that there are 7 times more MSF cases
than officially reported (15,16). Seroepidemiological
findings also support this concept. In Europe and in
countries with a Mediterranean shore, the prevalence
of antibodies against R. conorii in individuals living
in cities is usually between 2% and 30% (13,18-20).
However, in people who live in rural areas, it is
seen at a higher level (10%-60%) (19-22). In 1998,
Vural et al. found R. conorii antibody in 13.27% of
humans in the rural areas of Antalya district, which
is located in the Mediterranean region of Turkey (8).
The present study is a seroepidemiological proof that
this region, which is endemic for CCHFV, can also
be an endemic region for MSF. For all that, the cross
serologic reaction may be between R. conorii and
other Rickettsia spp. Since the results obtained by the
tests (R. conorii-IgG ELISA) have not been confirmed
by additional tests and false positive reactions are not
ruled out, these findings were evaluated as possible
results.
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The antibody prevalence to R. conorii, which was
higher in men compared to women, may be due to
men dealing with farming and ranching activities at
a higher level in Tokat region.
Because the long-term persistence of detectable
antibodies in SFG rickettsial infections is usual (23),
long-lasting antibody titers may be one of the reasons
for the high prevalence of antibody to R. conorii in
older age groups. In this region, the length of farming
and ranching throughout the day increases with age
and this may cause the increment of possible tick bite
exposure. In addition, older individuals, who have
lower educational level than younger individuals,
may show lower sensitivity about personal protection
against tick bites.
In the present study, a higher seroprevalence in
individuals who had been exposed to tick bite than
those who had no previous tick bite history was
expected because R. conorii is transmitted by ticks.
However, in this study in individuals with no previous
tick bite history, R. conorii seroprevalence was also
observed to be considerably high. The nymph and
larvae forms of ticks can also be infected by R. conorii
(1). In those without a history of tick bite, one of the
reasons for seropositivity could be unnoticed tick
bites, egg nymphs, and larvae, which are small and
feed for shorter times than adults.
For R. conorii seropositivity, the finding of no
difference between people who removed the ticks by
hand and with people who had no contact with ticks
shows that cutaneous contact with ticks does not have
much effect on the transmission to humans for this
agent. Even if such an infection occurs, it is probably
very rare. To the best of our knowledge, there is no
report in the literature regarding such a transmission.
In the current study, because the seroprevalence
of R. conorii was found higher in Group 1 than in
Group 2 in terms of all parameters (Table 2), an
epidemiological similarity was presented between
CCHFV and R. conorii. The fact that individuals with
antibodies to CCHFV are in a high risk group for tick
borne infections is one of the major reasons for the
epidemiological similarity between them. Especially
the tick bite rate and mean age being higher in Group
1 compared to Group 2 is one of the major factors
of this similarity. Besides tick bite and age, other
factors, such as education level and habitual attitude

T. GÜNEŞ, Ö. POYRAZ, M. ATAŞ, N. H. TURGUT

before and after tick bite, may play a role for the
epidemiological similarity.
H. marginatum, R. bursa, and R. turanicus ticks,
apart from R. sanguineus, may also play a significant
role as enzootic vectors of MSF (24,25). It is reported
that H. marginatum, which is the primary vector for
CCHFV, and R. bursa ticks were encountered as the
most dominant species within the ticks collected from
animals in Tokat (26). Observing the ticks having
a role in the widespread enzootic transmission of
both infection agents may be another reason for the
epidemiological similarity between both infectious
agents.
Prevalence of the tick-borne infections in humans
living in certain geographical areas is determined
by several factors, such as density of the vector
ticks, the prevalence of infectious agents in ticks,
geographical structure and climate, and the human

activities leading to high tick-human contact (1,9).
High prevalence of CCHF and MSF cases in Tokat
Province could be a combinatorial effect of these
factors. Consequently, our data confirm the fact that
rickettsiosis could be a significant health problem in
many parts of Turkey and the study shows that people
who are in a risk group for CCHF, are likely to be in a
risk group for R. conorii.
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